“Up until this moment, she felt only the deep anxiety she has been struggling with every day, but an instant later she begins to feel good about her life. In a matter of seconds, the restrictions lift. She feels lighter, […]
“The answer became clear as the monthly questionnaires started rolling in. The number of attacks the participants suffered at home really was dropping. It fell by 40 percent after the onset of the pandemic.” | learn more
“A team of biohackers is on a David-versus-Goliath mission to make insulin affordable to an increasing number of diabetics.” | learn more
This is still only the beginning. “Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday.” | learn more
The Economist fast forwards 10 years into the future. The story “is fiction, but grounded in historical fact, current speculation and real science.” | learn more
“Extending the human lifespan beyond 100 years.” Sinclair is a geneticist and world-leading expert on longevity. | learn more
“Fitness trackers are often mainly used to count steps but your heart-rate metrics can also be revealing, doctors say” | learn more
On the heels of last week’s Peter Attia link, here’s his fleshed out article full of citations. “Some experts suggest CGMs are useless for nondiabetics. I disagree.” For those new to Peter Attia, he’s a practicing physician (MD) focusing on the […]
“Additionally, Peter explains why he encourages all his patients, even nondiabetics, to utilize a continuous glucose monitor (CGM) which gives important insights that traditional lab testing and metrics consistently miss.” Related: NutriSense! | learn more
Coming soon: “At FOXO Technologies, we are committed to developing a new underwriting protocol based on the science of epigenetics.” | learn more